Carna Health, Siemens Healthineers Partner on Kidney Care

Carna Health, a digital health company specializing in kidney care, began an agreement with Siemens Healthineers to speed adoption of Carna’s artificial intelligence (AI)-enabled chronic kidney disease (CKD) platform and bring point of care testing systems to emerging markets.

The duo, by integrating Carna Health’s digital health platforms with Siemens Healthineers’ global diagnostics infrastructure, hopes to improve early detection and CKD management for high-risk and underserved populations. They also aim to simplify CKD workflow by creating better pathways for referrals, providing timely nephrology care, and reduce costs.

A population-based CKD screening program in Bermuda and Limbe, Cameroon, is currently enrolling 30,000 individuals across the Southwest and Littoral regions. The program merges Carna’s digital platform with point-of-care eGFR testing on Siemens Healthineers’ epoc blood analysis system to bring lifesaving care to communities that have challenges with accessing care. Carna plans to enroll 25 million people in CKD screening programs worldwide by 2030, with plans to expand the platform to screen for other cardiometabolic diseases like diabetes.

Carna Health’s platform lets healthcare providers identify and track CKD through AI-driven clinical decision support and community-based screening programs. The company is an authorized reseller of Siemens Healthineers diagnostic solutions in combination with its exclusive digital health distribution rights for CKD-related products in the Philippines, Bermuda, and Cameroon.

“This strategic agreement marks a turning point in the fight against CKD,” said Salvatore Viscomi, MD, Co-Founder and CEO of Carna Health. “By combining Carna’s AI-enabled platform with global diagnostics expertise from Siemens Healthineers, we’re delivering a unified approach to early identification, continuous monitoring, and proactive management of CKD. Together we can detect disease sooner, connect patients to care faster, and enable interventions that change health outcomes and save lives.”

“We have a shared commitment to expanding digital and diagnostic testing innovation access in regions around the world where such technologies have historically been limited,” added Bethany Costello, head of Global Strategy for point of care diagnostics at Siemens Healthineers. “Combining forces will build more equitable kidney care pathways for patients globally.”